Artificial intelligence news.
Straight from the original announcements.

ScreenPoint Medical Names Parul Sharma Chief Commercial Officer

November 16, 2026, 10:00By the AI News Bites Editorial TeamSource: PR Newswire
ScreenPoint Medical Names Parul Sharma Chief Commercial Officer
Image: PR Newswire

ScreenPoint Medical has appointed Parul Sharma as its chief commercial officer, adding her to the company's Management Team. She will lead the global go-to-market strategy across sales, marketing, customer success, partnerships and revenue operations.

Key points
  • Parul Sharma joins ScreenPoint Medical's Management Team as chief commercial officer.
  • She will lead global sales, marketing, customer success, partnerships and revenue operations.
  • Sharma most recently served as chief commercial officer at Viedoc.
  • ScreenPoint Medical says more than 15 million mammograms have been processed worldwide.
  • The company is participating in the MASAI, PRISM and AIMS randomised controlled trials.

Sharma takes charge of commercial operations

Sharma will oversee ScreenPoint Medical's commercial strategy and execution as the company expands its breast cancer AI business. Her responsibilities will span the functions that support customer acquisition, retention and revenue generation, including sales, marketing, customer success, partnerships and revenue operations.

"What attracted me to ScreenPoint Medical is the opportunity to bring together innovative technology and strong clinical evidence that translates into meaningful impact for women," Sharma said in the company's announcement. She added that she would work with the team to build on its global momentum, accelerate adoption of Transpara and bring the benefits of Breast AI to more healthcare providers and patients around the world.

Commercial leadership across software businesses

Since 2016, Sharma has held C-level commercial leadership positions across several software verticals. The company said her previous roles included work at Hansoft, Besedo and Bannerflow.

Most recently, Sharma was chief commercial officer at Viedoc, an Electronic Data Capture platform for clinical trial data serving sponsors and study sites. ScreenPoint Medical said she brings experience in commercial leadership, revenue growth and scaling technology businesses.

Sharma received an undergraduate degree in Biochemistry from Delhi University and a postgraduate degree in Brand Management from Mudra Institute of Communications. She resides in Stockholm.

ScreenPoint points to global adoption of Breast AI

ScreenPoint Medical said the appointment comes as it sees significant global traction and increasing adoption of AI solutions for breast cancer. More than 15 million mammograms have been processed worldwide to date, according to the company.

The company said commercial momentum has accelerated in the United States, Europe and other markets over the past year. It also continues to participate in clinical research through landmark randomised controlled trials including MASAI, PRISM and AIMS.

CEO Pieter Kroese said healthcare providers and programmes are adopting AI to pursue greater clinical impact for patients and operational value for practices. He described Sharma as having a proven record of working with teams and organisations to translate new technologies into tangible outcomes.

For ScreenPoint Medical, Sharma's appointment puts a dedicated commercial leader in charge of turning that research activity and reported usage into wider adoption. The company says its Transpara Breast AI is trusted by radiologists and women across the globe, and positions the product as its Breast AI offering.

ScreenPoint MedicalParul SharmaTransparaMASAIPRISMAIMShealthcareenterprise AI

Related news

SAS and Posit join forces on governed AI for life sciences
BusinessNovember 16, 2026, 09:00

SAS and Posit join forces on governed AI for life sciences

SAS and Posit have partnered to help life science organizations combine SAS and open source technologies, initially focusing on clinical development. The integration is…

SAS and Posit Partner on Governed AI for Life Sciences
BusinessNovember 16, 2026, 09:00

SAS and Posit Partner on Governed AI for Life Sciences

SAS and Posit PBC have formed a partnership to give life sciences organizations more flexibility in using SAS and open-source technologies, initially for clinical…

SAS and Posit partner to bring governed open source AI to life sciences
BusinessNovember 16, 2026, 09:00

SAS and Posit partner to bring governed open source AI to life sciences

SAS and Posit PBC are partnering to give life sciences organizations more flexibility to use SAS and open source technologies in regulated clinical development. The…